Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company’s 2019 Most Innovative Companies in Biotech.
EMERYVILLE, Calif., Feb. 20, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has been named one of Fast Company's 2019 Most Innovative Companies in Biotech. Fast Company's Most Innovative Companies rankings recognize trailblazers that have made a significant and lasting impact in their respective industries. Berkeley Lights was recognized for delivering technology that fundamentally changes and significantly accelerates cell biology and biotechnology workflows.
"It is an honor to be selected as one of the World's Most Innovative Companies for 2019 by Fast Company. In an era where cell-based products are changing healthcare, agriculture and synthetic biology, yet can take 10 years or more to develop, Berkeley Lights' optofluidic platform enables companies to select the best cells for their specific applications and drive forward with greater efficiency than previously possible," said Eric Hobbs, CEO of Berkeley Lights. "Our technology has demonstrated its ability to accelerate discovery and development and create significant savings in the pharmaceutical industry. We look forward to expanding our capabilities to meet a growing and diversifying scope of applications."
Berkeley Lights' digital cell biology platform uses proprietary light-based technology and nanofluidics to automate cell cloning, culturing, assaying, and selection, shrinking traditional cell processing and screening timelines from months to weeks or even days. The Berkeley Lights platform can replace a room full of traditional equipment and delivers deeper insights into individual cells for vastly improved cell selection and live export of these cells for the next steps of development.
More than half of the world's top 20 biopharmaceutical companies have implemented BLI's platforms and, over the past year, adoption has increased more than 50 percent. The company recently closed a $95 million funding round that will be used to accelerate commercial efforts and expand its current product offerings to meet the needs of a growing customer base.
Fast Company's editors survey thousands of applicants across 41 categories from biotech to consumer electronics to identify who they feel are the most notable innovators for the year to come. Previous winners include Ginkgo Bioworks, Spark Therapeutics, and 23andMe, as well as tech powerhouses like Apple and Amazon. You may read more about Berkeley Lights in the latest issue of Fast Company, which hits newsstands February 26 and can be found online at www.fastcompany.com/MIC.
About Berkeley Lights
Berkeley Lights, Inc. (BLI) is a digital cell biology company that develops and commercializes platforms for the acceleration of discovery, development, and delivery of cell-based products and therapies.
At the intersection of biology, technology and information, our platforms automate the manipulation, analysis and selection of individual cells, creating ultimate scalability and deep cell insights. The Beacon platform* is ideally suited for cell line development, antibody discovery (including direct B-cell workflows), gene editing, and antibody engineering workflows. Each workflow provides a 100 fold increase in insights, 10 times faster, at a fraction of the cost.
For more information, visit http://www.berkeleylights.com/.
* For Research Use Only. Not for use in diagnostic procedures.
View original content to download multimedia:http://www.prnewswire.com/news-releases/berkeley-lights-selected-as-one-of-the-worlds-most-innovative-companies-of-2019-by-fast-company-300798341.html
SOURCE Berkeley Lights, Inc.
